These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25006843)

  • 1. [Resistance to second-line drugs in migrants with multidrug-resistant tuberculosis in the Berlin region].
    Otto-Knapp R; Bös L; Schönfeld N; Wagner S; Starzacher AK; Weiss T; Vesenbeckh S; Glaser-Paschke G; Mauch H; Rüssmann H; Bauer TT
    Pneumologie; 2014 Jul; 68(7):496-500. PubMed ID: 25006843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
    Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil.
    da Silva Garrido M; Ramasawmy R; Perez-Porcuna TM; Zaranza E; Chrusciak Talhari A; Martinez-Espinosa FE; Bührer-Sékula S
    Int J Tuberc Lung Dis; 2014 May; 18(5):559-63. PubMed ID: 24903793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
    Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
    J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G; Miörner H; Ahmed O; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
    Shen X; Li J; Gao Q; Xu B; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis.
    Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM
    Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.
    Lu PL; Peng CF; Hwang JJ; Chen YH
    J Chemother; 2008 Apr; 20(2):202-7. PubMed ID: 18467246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity Pattern of Second Line Anti-Tuberculosis Drugs against Clinical Isolates of Multidrug Resistant Mycobacterium tuberculosis.
    Ghafoor T; Ikram A; Abbasi SA; Zaman G; Ayyub M; Palomino JC; Vandamme P; Martin A
    J Coll Physicians Surg Pak; 2015 Apr; 25(4):250-3. PubMed ID: 25899188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistant lung tuberculosis in Berlin 1987-1993].
    Schaberg T; Gloger G; Reichert B; Mauch H; Lode H
    Pneumologie; 1996 Jan; 50(1):21-7. PubMed ID: 8774931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy.
    Balabanova Y; Ruddy M; Hubb J; Yates M; Malomanova N; Fedorin I; Drobniewski F
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):136-9. PubMed ID: 15666160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2007; 75(1):32-9. PubMed ID: 17541910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.
    Cambau E; Viveiros M; Machado D; Raskine L; Ritter C; Tortoli E; Matthys V; Hoffner S; Richter E; Perez Del Molino ML; Cirillo DM; van Soolingen D; Böttger EC
    J Antimicrob Chemother; 2015 Mar; 70(3):686-96. PubMed ID: 25587993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
    Zhang Z; Li T; Qu G; Pang Y; Zhao Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.